Hamps Bio Limited, a company listed on the Bombay Stock Exchange (BSE) under the scrip code 544312, has announced a revision to the record date for its proposed bonus equity share issue. The company has changed the record date from September 8, 2025, to September 9, 2025, following communication from the BSE.

Bonus Share Details

The company plans to issue bonus shares in a 1:1 ratio, meaning shareholders will receive:

• One bonus equity share of Rs. 10 each
• For every one existing fully paid-up equity share of Rs. 10 each

This bonus share issuance was approved by shareholders through an ordinary resolution at the company's 18th Annual General Meeting held on August 30, 2025.

Revised Record Date

The revision in the record date was made in response to an email received from the Bombay Stock Exchange on September 5, 2025.

Company Background

Hamps Bio Limited, previously known as Hamps Bio Pvt. Ltd., is identified by the Corporate Identification Number (CIN) L24233GJ2007PLC049692. The company operates two manufacturing units:

1. Unit-1: Located at 2900/112, G.I.D.C. Industrial Estate, Nr. Atul Ltd., Ankleshwar - 393002
2. Unit-2: Situated at Plot No. C1-B-108, Nr- Mama Bhanja Factory, Bhatpore G.I.D.C., Surat, Gujarat, India 394510

Management Statement

Herrik Mountbaton Shah, the Managing Director & Chairman of Hamps Bio Limited, signed the official communication to the BSE regarding the record date revision. The company has requested the stock exchange to acknowledge and update their records accordingly.

Investors and shareholders of Hamps Bio Limited should take note of this revised record date for the upcoming bonus share issue. As always, it is advisable for stakeholders to keep track of official company announcements and consult with financial advisors for any investment-related decisions.

Hamps Bio Limited , a prominent player in the biotechnology sector, has made significant announcements following its recent board meeting. The company has approved a bonus share issue and set the date for its 18th Annual General Meeting (AGM), among other important decisions.

Bonus Share Issue

The board of Hamps Bio Limited has approved the issuance of bonus shares in a 1:1 ratio, subject to shareholder approval. This means that shareholders will receive one bonus equity share of Rs. 10 each for every fully paid-up equity share held. The bonus issue will be funded from the company's free reserves and securities premium account, which totaled Rs. 444.45 lakhs as of March 31, 2025.

Impact on Share Capital

The bonus issue will have a significant impact on the company's share capital structure:

The total number of new equity shares to be issued is approximately 43.56 lakh, with a total value of Rs. 435.60 lakhs.

Annual General Meeting

The board has set the date for the 18th Annual General Meeting (AGM) for August 29, 2025. The meeting will be held at 4:00 PM at the company's registered office in Ankleshwar, Gujarat.

Other Key Decisions

1. Increase in Authorized Share Capital: The board approved an increase in the authorized share capital of the company, with a consequential amendment to the Memorandum of Association.

2. Annual Report Approval: The draft annual report for the financial year ended March 31, 2025, has been approved.

3. Director Reappointment: Mr. Shrenikkumar Mountkumar Shah (DIN - 00973690), who retires by rotation, has been appointed for re-election.

4. Secretarial Audit: The board noted the Secretarial Audit report issued by M/S Richa Goyal & Associates for the financial year ended March 31, 2025.

5. AGM Scrutinizer: Mrs. Richa Manoj Goyal, a Practicing Company Secretary, has been appointed as the scrutinizer for the 18th AGM.

Timeline for Bonus Shares

The company expects to credit or dispatch the bonus shares within two months from the date of the board meeting, by September 28, 2025.

These developments signify Hamps Bio Limited's commitment to rewarding its shareholders and maintaining transparency in its corporate governance practices. Investors and stakeholders will be keenly watching the upcoming AGM for further insights into the company's performance and future strategies.